Improvement of 'dynamic analgesia' does not decrease atelectasis after thoracotomy
N Boisseau, O Rabary, B Padovani, P Staccini, J Mouroux, D Grimaud, M Raucoules-Aimé, N Boisseau, O Rabary, B Padovani, P Staccini, J Mouroux, D Grimaud, M Raucoules-Aimé
Abstract
There is still controversy concerning the beneficial aspects of 'dynamic analgesia' (i.e. pain while coughing or moving) on the reduction of postoperative atelectasis. In this study, we tested the hypothesis that thoracic epidural analgesia (TEA) prevents these abnormalities as opposed to multimodal analgesia with i.v. patient controlled analgesia (i.v. PCA) after thoracotomy. Fifty-four patients undergoing thoracotomy (lung cancer) were randomly assigned to one of the two groups. Clinical respiratory characteristics, arterial blood gas, and pulmonary function tests (forced vital capacity and forced expiratory volume in 1 s) were obtained before surgery and on the next 3 postoperative days. Atelectasis was compared between the two groups by performing computed tomography (CT) scan of the chest at day 3. Postoperative respiratory function and arterial blood gas values were reduced compared with preoperative values (mean (SD) FEV1 day 0: 1.1 (0.3) litre; 1.3 (0.4) litre) but there was no significant difference between groups at any time. PCA and TEA provided a good level of analgesia at rest (VAS day 0: 21 (15/100); 8 (9/100)), but TEA was more effective for analgesia during mobilization (VAS day 0: 52 (3/100); 25 (17/100)). CT scans revealed comparable amounts of atelectasis (expressed as a percentage of total lung volume) in the TEA (7.1 (2.8)%) and in the i.v. PCA group (6.71 (3.2)%). There was no statistical difference in the number of patients presenting with at least one atelectasis of various types (lamellar, plate, segmental, lobar).
Source: PubMed
Upcoming Clinical Trials
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and Applied...Not yet recruitingMotor Skills | Healthy | Executive Function
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCNot yet recruitingAnal Squamous Cell Carcinoma
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaNot yet recruitingRheumatoid Arthritis | Degenerative Joint Disease of KneeItaly
-
University of Wisconsin, MadisonAlkermes, Inc.Not yet recruiting
-
Virginia Commonwealth UniversityNot yet recruitingCerebral Edema | Radiation NecrosisUnited States
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at Mount...Not yet recruitingKetamine | fMRI | Depression - Major Depressive Disorder | rTMS | Treatment-resistant Depression (TRD)United States
-
Weill Medical College of Cornell UniversityBD2 LLCNot yet recruitingfMRI | Bipolar Disorder (BD) | rTMS | Bipolar 1 DepressionUnited States
-
Xentria, Inc.Not yet recruiting
-
Yale UniversityNational Institute of Mental Health (NIMH)Not yet recruiting
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruitingPheochromocytoma | Pheochromocytoma/Paraganglioma | Pheochromocytoma, Metastatic | Pheochromocytoma Malignant | Pheochromocytoma and Paraganglioma (PPGL)United Kingdom
-
Carl Zeiss Meditec-Dublin CoCeRecruitingEpiretinal Membrane | Retina Disease | Dry Age Related Macular Degeneration | Vitreoretinal Abnormality | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal Pigment Epithelium...United States
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical UniversityRecruiting